{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:23:50Z","timestamp":1765545830602},"reference-count":25,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":2878,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Comparative effectiveness research methods are used to compare the effect of four distinct glucose-control strategies on subsequent myocardial infarction and nephropathy in type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>A total of 58,000 adults with type 2 diabetes and A1C &amp;lt;7% (53 mmol\/mol) while taking two or more oral agents or basal insulin had subsequent A1C \u22657% (53 mmol\/mol) to 8.5% (69 mmol\/mol). Follow-up started on date of first A1C \u22657% and ended on date of a specific clinical event, death, disenrollment, or study end. Glucose-control strategies were defined as first intensification of glucose-lowering therapy at A1C \u22657, \u22657.5, \u22658, or \u22658.5% with subsequent control for treatment adherence. Logistic marginal structural models were fitted to assess the discrete-time hazards for each dynamic glucose-control strategy, adjusting for baseline and time-dependent confounding and selection bias through inverse probability weighting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>After adjustment for age, sex, race\/ethnicity, comorbidities, blood pressure, lipids, BMI, and other covariates, progressively more aggressive glucose-control strategies were associated with reduced onset or progression of albuminuria but not associated with significant reduction in occurrence of myocardial infarction or preserved renal function based on estimated glomerular filtration rate over 4 years of follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>In a large representative cohort of adults with type 2 diabetes, more aggressive glucose-control strategies have mixed short-term effects on microvascular complications and do not reduce the myocardial infarction rate over 4 years of follow-up. These findings are consistent with the results of recent clinical trials, but confirmation over longer periods of observation is needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc12-2675","type":"journal-article","created":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T04:15:05Z","timestamp":1374552905000},"page":"3510-3516","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":18,"title":["Impact of Specific Glucose-Control Strategies on Microvascular and Macrovascular Outcomes in 58,000 Adults With Type 2 Diabetes"],"prefix":"10.2337","volume":"36","author":[{"given":"Romain","family":"Neugebauer","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Fireman","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Clinical Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"HealthPartners Institute for Education and Research, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2013,10,15]]},"reference":[{"key":"2022031302182847200_B1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc12-s011","article-title":"Standards of medical care in diabetes\u20142012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031302182847200_B2","unstructured":"Institute for Clinical Systems Improvement. Diagnosis and management of type 2 diabetes mellitus in adults [article online], 2012. Available from https:\/\/www.icsi.org\/guidelines__more\/catalog_guidelines_and_more\/catalog_guidelines\/catalog_endocrine_guidelines\/diabetes\/. Accessed 14 May 2012"},{"key":"2022031302182847200_B3","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031302182847200_B4","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031302182847200_B5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031302182847200_B6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"2022031302182847200_B7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2042018810390545","article-title":"Near-normalization of glucose and microvascular diabetes complications: data from ACCORD and ADVANCE","volume":"2","author":"O\u2019Connor","year":"2011","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2022031302182847200_B8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"Gerstein","year":"2011","journal-title":"N Engl J Med"},{"key":"2022031302182847200_B9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/ije\/26.2.461","article-title":"Validity of ICD code 410 to identify hospital admission for myocardial infarction","volume":"26","author":"Tunstall-Pedoe","year":"1997","journal-title":"Int J Epidemiol"},{"key":"2022031302182847200_B10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J"},{"key":"2022031302182847200_B11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/oxfordjournals.aje.a121590","article-title":"Kaiser-Permanente epidemiologic study of myocardial infarction. Study design and results for standard risk factors","volume":"99","author":"Friedman","year":"1974","journal-title":"Am J Epidemiol"},{"key":"2022031302182847200_B12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/aje\/kwh341","article-title":"Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000","volume":"160","author":"Rosamond","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2022031302182847200_B13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ije\/20.1.114","article-title":"Identification of cases of myocardial infarction: hospital discharge data and mortality data compared to myocardial infarction community registers","volume":"20","author":"Hammar","year":"1991","journal-title":"Int J Epidemiol"},{"key":"2022031302182847200_B14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/pds.3253","article-title":"Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes","volume":"21","author":"Neugebauer","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022031302182847200_B15"},{"key":"2022031302182847200_B16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hern\u00e1n","year":"2000","journal-title":"Epidemiology"},{"key":"2022031302182847200_B17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/aje\/155.11.1045","article-title":"Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians\u2019 Health Study","volume":"155","author":"Cook","year":"2002","journal-title":"Am J Epidemiol"},{"key":"2022031302182847200_B18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/aje\/kwh131","article-title":"Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology","volume":"159","author":"Bodnar","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2022031302182847200_B19"},{"key":"2022031302182847200_B20","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1002\/sim.3301","article-title":"Estimation and extrapolation of optimal treatment and testing strategies","volume":"27","author":"Robins","year":"2008","journal-title":"Stat Med"},{"key":"2022031302182847200_B21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005285815569","article-title":"Association, causation and marginal structural models","volume":"121","author":"Robins","year":"1999","journal-title":"Synthese"},{"key":"2022031302182847200_B22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"2022031302182847200_B23","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/sim.4469","article-title":"Causal inference in epidemiological studies with strong confounding","volume":"31","author":"Moore","year":"2012","journal-title":"Stat Med"},{"key":"2022031302182847200_B24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/bmj.317.7160.720","article-title":"Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"2022031302182847200_B25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/11\/3510\/614367\/3510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/11\/3510\/614367\/3510.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T06:28:50Z","timestamp":1647152930000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/36\/11\/3510\/38112\/Impact-of-Specific-Glucose-Control-Strategies-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,15]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,10,15]]},"published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc12-2675","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,15]]}}}